Search company, investor...

Quotient Diagnostics

quotientdiagnostics.co.uk

Founded Year

2002

Stage

Acquired | Acquired

Total Raised

$1.52M

Valuation

$0000 

About Quotient Diagnostics

Quotient Diagnostics is a company with a novel patented assay technology to address one of the most rapidly developing medical problems the world faces today: the diagnosis, treatment and management of diabetes.

Headquarters Location

55 Central Avenue West Molesey

Surrey, England, KT8 2QT,

United Kingdom

Missing: Quotient Diagnostics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Quotient Diagnostics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Quotient Diagnostics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Quotient Diagnostics is included in 1 Expert Collection, including Diabetes.

D

Diabetes

1,898 items

Quotient Diagnostics Patents

Quotient Diagnostics has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/23/2007

8/16/2011

Hemoglobins, Proteinogenic amino acids, Molecular biology, Glucogenic amino acids, Biotechnology

Grant

Application Date

3/23/2007

Grant Date

8/16/2011

Title

Related Topics

Hemoglobins, Proteinogenic amino acids, Molecular biology, Glucogenic amino acids, Biotechnology

Status

Grant

Latest Quotient Diagnostics News

IQ Capital Partners LLP - Seed Funds - QUOTIENT DIAGNOSTICS SECURES £1 MILLION FUNDING TO MOVE INTO PRODUCTION

Feb 8, 2015

Quotient Diagnostics Secures £1 Million Funding to Move into Production March 2008 Quotient Diagnostics , developer of a new diabetes testing technology, has secured a further round of investment allowing it to take its Quo-Test system into production. The company is focussing on a diabetes indicator known as A1c, which is a component of haemoglobin and an important indicator of a diabetic's long-term condition. The A1c test is used to check how well patients have their condition under control. With the rapid spread of diabetes around the world, clinicians increasingly look to A1c to help them tackle it. Quo-Test is significantly faster, cheaper and simpler to use than the alternative of sending a blood sample away for laboratory analysis. It provides a result in around 4 minutes, making it possible for a doctor or nurse to get a reading on the spot, so reducing costs and waiting times. From its foundation in 2003, Quotient has been backed by an investor syndicate including GEIF Ventures , NESTA , The Capital Fund LP , and a group of angel investors. They were joined later by trade partner BBI Holdings. In this new round, the company's fourth, the previous investors have been joined by a further 13 angels, who account for half of the £1 million raised. The majority of newcomers are members of London Business Angels. Dr. Greg Davidson, Quotient's CEO, said: "This is another major step forward for the company. The shift from R&D to production is one that many a high-tech start-up never actually achieves. We always felt that there would be great market potential for our system and we are now poised to prove this. We are deeply grateful to investors old and new for their vote of confidence in us. "

Quotient Diagnostics Frequently Asked Questions (FAQ)

  • When was Quotient Diagnostics founded?

    Quotient Diagnostics was founded in 2002.

  • Where is Quotient Diagnostics's headquarters?

    Quotient Diagnostics's headquarters is located at 55 Central Avenue, Surrey.

  • What is Quotient Diagnostics's latest funding round?

    Quotient Diagnostics's latest funding round is Acquired.

  • How much did Quotient Diagnostics raise?

    Quotient Diagnostics raised a total of $1.52M.

  • Who are the investors of Quotient Diagnostics?

    Investors of Quotient Diagnostics include EKF Diagnostics, The Capital Fund, GEIF Ventures Early Growth Fund, Nesta, BBI Holdings and 7 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.